Esperanza Martin Sanchez-rekin lankidetzan egindako argitalpenak (4)

2014

  1. PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases

    PLoS ONE, Vol. 9, Núm. 11

  2. PLCG1 mutations in cutaneous T-cell lymphomas

    Blood, Vol. 123, Núm. 13, pp. 2034-2043

2013

  1. NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells

    Clinical Cancer Research, Vol. 19, Núm. 9, pp. 2319-2330

  2. Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas

    Haematologica, Vol. 98, Núm. 1, pp. 57-64